Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma

Carbohydrate antigen 19·9 accurately sel

Carbohydrate antigen 19·9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy

✍ C. M. Halloran; P. Ghaneh; S. Connor; R. Sutton; J. P. Neoptolemos; M. G. T. Rar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

## Abstract ## Background Laparoscopy with laparoscopic ultrasonography (L–LUS) may be useful in the selection of patients for surgery to resect peripancreatic malignancy in addition to contrast-enhanced computed tomography (CE–CT). The present prospective study assessed the strategy of using carb